Evidence map›Paper›PMID 40760332›Full record

ReviewInnere Medizin (Heidelberg, Germany)2025

[The importance of sex/gender for graft and patient survival].

Zhejia Tian, Anette Melk

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhejia TianKlinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Hannover, Deutschland.
Anette MelkKlinik für Pädiatrische Nieren‑, Leber- und Stoffwechselerkrankungen und Neuropädiatrie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Deutschland. melk.anette@mh-hannover.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organ transplantation is the treatment of choice for patients with end-stage organ failure. Sex/gender differences in transplantation are extremely relevant, yet understudied. They are significant for every step in the transplantation process: from evaluation, listing, and acceptance onto the waiting list, to transition from the waiting list to transplantation, and finally to short- and long-term transplant survival. Ultimately, sex/gender differences also affect patient survival. Registry analyses often consider sex and gender only as a modifying factor, and women are underrepresented in clinical trials in transplantation medicine. The causes of these differences include not only biological factors (sex), but also psychosocial, socioeconomic, and cultural factors (gender). The current lack of consideration of sex/gender-specific differences leads to disadvantages. More targeted basic and clinical research must contribute to understanding the underlying mechanisms of these differences and applying them in diagnostic and therapeutic approaches.

Indexed as

Graft SurvivalOrgan TransplantationFemaleHumansMaleRegistriesSex FactorsWaiting ListsPatient survivalSex and gender disparitiesTransplantationTransplantat survivalWaitlist

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.